Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

References for PMC Articles for PubMed (Select 20088827)


Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation.

Kristo F, Hardy GJ, Anderson TJ, Sinha S, Ahluwalia N, Lin AY, Passeri J, Scherrer-Crosbie M, Gerszten RE.

Atherosclerosis. 2010 May;210(1):107-13. doi: 10.1016/j.atherosclerosis.2009.11.031. Epub 2009 Nov 26.


ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL, Daugherty A.

Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1660-5. doi: 10.1152/ajpheart.00028.2009. Epub 2009 Feb 27.


Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC 3rd.

N Engl J Med. 2008 Jun 26;358(26):2787-95. doi: 10.1056/NEJMoa0706585.


Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice.

Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA.

Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1251-6. doi: 10.1161/ATVBAHA.107.160382. Epub 2008 May 1.


Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial.

Ahimastos AA, Aggarwal A, D'Orsa KM, Formosa MF, White AJ, Savarirayan R, Dart AM, Kingwell BA.

JAMA. 2007 Oct 3;298(13):1539-47.


Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.

Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB, Klein GL, Li JS, Minich LL, Paridon SM, Pearson GD, Printz BF, Pyeritz RE, Radojewski E, Roman MJ, Saul JP, Stylianou MP, Mahony L; Pediatric Heart Network Investigators.

Am Heart J. 2007 Oct;154(4):624-31.


Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model.

Miyake T, Aoki M, Masaki H, Kawasaki T, Oishi M, Kataoka K, Ogihara T, Kaneda Y, Morishita R.

Circ Res. 2007 Nov 26;101(11):1175-84. Epub 2007 Sep 20.


Marfan syndrome: from molecular pathogenesis to clinical treatment.

Ramirez F, Dietz HC.

Curr Opin Genet Dev. 2007 Jun;17(3):252-8. Epub 2007 Apr 27. Review. Erratum in: Curr Opin Genet Dev. 2007 Aug;17(4):367.


Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.

Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF.

J Clin Invest. 2007 Apr;117(4):902-9. Epub 2007 Mar 15.


Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.

Cassis LA, Rateri DL, Lu H, Daugherty A.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):380-6. Epub 2006 Dec 7.


Rapid dilation of the abdominal aorta during infusion of angiotensin II detected by noninvasive high-frequency ultrasonography.

Barisione C, Charnigo R, Howatt DA, Moorleghen JJ, Rateri DL, Daugherty A.

J Vasc Surg. 2006 Aug;44(2):372-6.


Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC.

Science. 2006 Apr 7;312(5770):117-21.


Marfan's syndrome.

Judge DP, Dietz HC.

Lancet. 2005 Dec 3;366(9501):1965-76. Review.


Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase.

Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K, Matsuzaki M.

Nat Med. 2005 Dec;11(12):1330-8. Epub 2005 Nov 27.


Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice.

Babamusta F, Rateri DL, Moorleghen JJ, Howatt DA, Li XA, Daugherty A.

Atherosclerosis. 2006 Jun;186(2):282-90. Epub 2005 Sep 8.


Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice.

Ayabe N, Babaev VR, Tang Y, Tanizawa T, Fogo AB, Linton MF, Ichikawa I, Fazio S, Kon V.

Atherosclerosis. 2006 Feb;184(2):312-21. Epub 2005 Jul 14.


Development of experimental designs for atherosclerosis studies in mice.

Daugherty A, Rateri DL.

Methods. 2005 Jun;36(2):129-38.


Differential effects of angiotensin II on atherogenesis at the aortic sinus and descending aorta of apolipoprotein-E-deficient mice.

Zhou Y, Chen R, Catanzaro SE, Hu L, Dansky HM, Catanzaro DF.

Am J Hypertens. 2005 Apr;18(4 Pt 1):486-92.


Chemokines in the pathogenesis of vascular disease.

Charo IF, Taubman MB.

Circ Res. 2004 Oct 29;95(9):858-66. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk